ÔçÒÒŮѸÀ×

    1. <form id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></form>
      <address id=SSjMaZxIp><nobr id=SSjMaZxIp><nobr id=SSjMaZxIp></nobr></nobr></address>

      Current Value of Holding

      $901M

      Shares

      2.09M

      % of Portfolio

      31.71%

      Average Buy Price

      $225

      Avg closing price
      Price range

      8 John Paulson Madrigal Pharmaceuticals Trades

      John Paulson acquired 2.09M Madrigal Pharmaceuticals shares worth $901M. It makes up 31.71% of their stock portfolio and is their biggest holding. The investor owns 9.23% of the outstanding Madrigal Pharmaceuticals stock. John Paulson started to build up the position in Madrigal Pharmaceuticals in Q2 2023 and continued to invest until Q1 2025. Since then they sold 10k shares. The stake costed the investor $470M, netting the investor a gain of 92% so far.

      Avg closing price
      Price range
      Sold 0.5% shares (-10k shares) Q2 2025
      Avg closing price $297.20
      Price range $267.56 - $334.60
      Increased shares by 2.8% (+57.5k shares) Q1 2025
      Avg closing price $328.25
      Price range $272.79 - $355.88
      Increased shares by 10.4% (+192k shares) Q3 2024
      Avg closing price $255.94
      Price range $212.22 - $292.96
      Increased shares by 4.2% (+75k shares) Q2 2024
      Avg closing price $238.04
      Price range $193.33 - $291.99
      Increased shares by 60.5% (+669k shares) Q1 2024
      Avg closing price $235.62
      Price range $171.37 - $283.23
      Increased shares by 121.1% (+606k shares) Q4 2023
      Avg closing price $174.99
      Price range $120.40 - $237.13
      Increased shares by 42.8% (+150k shares) Q3 2023
      Avg closing price $188.22
      Price range $146.04 - $225.78
      New holding (+350k shares) Q2 2023
      Avg closing price $270.85
      Price range $203.88 - $312.00

      News about Madrigal Pharmaceuticals Inc and John Paulson

      Paulson & Co. closes stake in Newmont, boosts Horizon Therapeutics stake

      Paulson & Co. closes stake in Newmont, boosts Horizon Therapeutics stake

      Paulson & Co. exits Newmont stake, increases holdings in Horizon Therapeutics and Madrigal Pharma.

      Seeking Alpha Seeking Alpha, almost 2 years ago
      Billionaire John Paulson¡¯s Messy Divorce and Top 5 Stock Picks

      Billionaire John Paulson¡¯s Messy Divorce and Top 5 Stock Picks

      In this article, we discuss billionaire John Paulson¡¯s Messy divorce and top 5 stock picks. If you want to see more stocks in this selection, check out Billi...

      Insider Monkey Insider Monkey, almost 2 years ago
      Paulson takes new stakes in Newmont, Iveric Bio and Madrigal in Q2

      Paulson takes new stakes in Newmont, Iveric Bio and Madrigal in Q2

      Paulson & Co., the fund headed by John Paulson, added new stakes in Iveric Bio (ISEE) (25K shares), Madrigal Pharmaceuticals (MDGL) (350K shares), and Newmon...

      Seeking Alpha Seeking Alpha, about 2 years ago

      Embed chart

      Easily embed the chart on your blog or website ¨C it will always update automatically!

      HoMEÔçÒÒŮѸÀ×